The Study of microRNA in Plasma to Discover Biomarkers  Important for Muscle Growth in Beef Cattle by Martin, Teresa Salas
THE STUDY OF microRNA IN PLASMA TO DISCOVER BIOMARKERS 
IMPORTANT FOR MUSCLE GROWTH IN BEEF CATTLE 
 
 
An Undergraduate Research Scholars Thesis 
by 
TERESA SALAS MARTIN 
 
 
Submitted to the Undergraduate Research Scholars program at  
Texas A&M University 
in partial fulfillment of the requirements for the designation as an 
 
 
UNDERGRADUATE RESEARCH SCHOLAR 
 
  
Approved by Research Advisor:           Dr. Penny K. Riggs 
 
 
May 2017 
 
 
Major: Animal Science  
TABLE OF CONTENTS 
 
Page 
ABSTRACT .................................................................................................................................. 1 
ACKNOWLEDGMENTS ............................................................................................................ 3 
NOMENCLATURE ..................................................................................................................... 4 
CHAPTER  
I. INTRODUCTION ...................................................................................................... 5 
II. METHODS ................................................................................................................. 7 
Animal Care and Handling ................................................................................... 7 
Plasma Collection and Processing ........................................................................ 7 
Isolation and Quantitative RT-PCR ...................................................................... 8 
Data Analysis ........................................................................................................ 8 
 
III. RESULTS AND DISCUSSION ............................................................................... 10 
Expression of miR-133b ..................................................................................... 10 
Expression of miR-27a ....................................................................................... 11 
Discussion ........................................................................................................... 11 
 
IV. CONCLUSION ......................................................................................................... 14 
REFERENCES ........................................................................................................................... 15 
  
1 
ABSTRACT 
The Study of microRNA in Plasma to Discover Biomarkers  
Important for Muscle Growth in Beef Cattle    
  
  
Teresa Salas Martin  
Department of Animal Science 
Texas A&M University 
 
 
Research Advisor: Dr. Penny K. Riggs 
Department of Animal Science 
Texas A&M University 
 
 
Producers are constantly looking for ways to improve muscle growth in cattle such that 
both the quantity and quality of beef can be increased. One approach is to examine expression of 
microRNAs as a potential selection tool. MicroRNAs are small RNA molecules that have 
regulatory functions in all metazoans. MiR-133b and miR-27a are known to affect muscle 
development through the IGF-1 pathway and their effect on the myostatin gene, respectively. 
Current research in humans has investigated microRNAs as biomarkers for diagnostic purposes. 
In the current experiment, we quantified the expression of miR-27a and miR-133b in order to 
evaluate their potential association with muscle growth traits. At approximately 12 month of age, 
44 crossbred steers received hormone implants and 44 were not given implants. Plasma was 
collected from the steers starting from day 0 and in 28 day intervals for 5 months. From the 
original collection, the plasma samples from 51 steers (28 implanted steers, and 21 control 
steers) were used for expression analyses. Hemolyzed samples were discarded from the 
experiment. MicroRNAs were extracted from the plasma, and the expression of the microRNAs 
was measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR) on the 
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Fluidigm Biomark HD platform. The amount of weight gained from Day 0 until harvest was 
determined for each steer, and then evenly separated into groups (high-gain and low-gain). The 
expression of miR-27a and miR-133b was compared between high gain steers and low gain 
steers. A difference in miR-133b and miR-27a expression was observed in the months of April 
and August, where an increase in miR-133b and miR-27a expression was observed in the low-
gain groups. 
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NOMENCLATURE 
 
miRNA microRNA 
qRT-PCR quantitative reverse transcription polymerase chain reaction  
RQ  Relative Quantification  
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CHAPTER I 
INTRODUCTION 
 
In order to meet consumer demands, producers look for strategies to not only increase the 
amount of muscle found on beef cattle, but also ways to ensure that the production of meat that is 
tender, juicy, and highly palatable. In order to increase yield, producers will utilize tools that 
may suppress protein degradation or increase protein synthesis.  An extreme example is the 
production of double muscled cattle. These cattle have a mutation in the myostatin gene, causing 
a significant increase in muscle mass compared to the average (McPherron and Lee, 1997). It has 
been found that the suppression of protein degradation causes a decrease in meat tenderness, 
while increased protein synthesis actually has no effect on meat tenderness (Koohmaraie et al., 
2002). Furthermore, it appears that the cattle with the suppressed myostatin gene produce meat 
that is much more tender than their counterparts (Koohmaraie et al., 2002).  
 
Recently, miRNAs have become of interest for use in identifying the potential of cattle. 
MicroRNAs are small RNA molecules (around 22-27 nucleotides long) that regulate protein 
synthesis in the body (Ambros, 2004). Since their first discovery about 20 years ago, it has been 
discovered that miRNAs provide a variety of functions, such as protection against viral infection, 
securing genome stability, and repressing protein synthesis (Daneholt, 2006). Recent research 
has looked into the use of microRNA’s found in blood plasma as biomarkers for conditions such 
as cancer (Tsujiura et al., 2010) and Alzheimer’s (Kiko et al., 2014). 
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Several microRNAs are known to be linked to muscular hyperplasia and muscular 
hypertrophy. MiR-133 is found in both cardiac and skeletal muscle, and is known to 
downregulate the insulin-like growth factor, a positive signal pathway that causes muscle growth 
by increasing protein synthesis and decreasing protein degradation (Wang, 2013). It acts by 
binding to the 3’ UTR region of IGF-1R, leading to a downregulation of the phosphorylation of 
Akt, which is the central mediator of the insulin-like growth factor (Huang et al., 2011). It has 
been found that miR-133 increases myoblast proliferation and decreases myoblast differentiation 
(Huang et al., 2012). Also, both miR-133a and miR-133b have been found to be upregulated 
during myogenesis (Feng et al., 2013). Recent studies have been trying to find miR-133’s role in 
muscle cancers and diseases, and to see if it could be used for therapy (Yu et al., 2014).  
 
Mir-27a has been found to increase muscle cell proliferation by directly inhibiting 
myostatin (Huang et al., 2012), and that a downregulation of this miRNA leads to muscle 
atrophy (Wang, 2013).     
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CHAPTER II 
METHODS 
 
Animal Care and Handling 
 Animal handling and sample collection procedures were approved by the Texas A&M 
University Animal Care and Use Committee (AUP #2008-234). In this study, a group of 88 F3 
Angus x Nellore steers were used that were approximately 12 months old when the first sample 
was collected. Implants were applied to 44 of the steers at approximately 12 months of age. The 
implants used were Component TE-S with Tylan (Elanco, Greenfield, IN, USA). The implants 
contained 24 mg of estradiol, 120 mg of trenbolone acetate, and 29 mg tylosin tartrate. Weights 
for the steers were measured every 28 days beginning at the first day the implant was added (Day 
0), and continuing until immediately prior to harvest.   
 
Plasma Collection and Processing  
 Blood was collected from the group of 88 steers every 28 days over a period of 7 months. 
The samples were collected using Vacuette® 18 ga x 1.5 inch multiple sample needles (PN 
450048, Greiner Bio-One North America, Monroe, NC, USA) by venipuncture and put into 10 
ml BD Vacutainer® tubes containing K2-EDTA (PN 366643, BD Diagnostics, Franklin Lakes, 
NJ, USA). The tubes were gently inverted 10 times immediately after collection as directed by 
the manufacturer. The blood was processed as soon as possible, except for the first (April) and 
second (May) sample collections, where the blood was processed 1 and 2 days following 
collection, respectively.  
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 The blood was processed by centrifugation at 1300 x g for 10 minutes,. Next, the plasma 
was removed with care in order not to disturb the buffy coat, and transferred to clear, 1.5 mL 
microcentrifuge tubes, at 500 μL aliquots and stored at -80°C.  
 
Isolation and Quantitative RT-PCR 
 Except when noted otherwise, all the procedure used during miRNA synthesis and qRT-
PCR followed manufacture’s protocols (Exiqon, Inc., Woburn, MA, USA). The miRNAs were 
extracted from 500 μL of plasma with the miRCURY TM RNA-Isolation Kit-Biofluids (Exiqon). 
The miRNA’s were quantified using the Qubit® microRNA Assay Kit on the Qubit® 2.0 
fluorometer. However, the RNA volume input was not adjusted to normalize RNA mass. 
Universal cDNA Synthesis Kit II (Exiqon) was used to perform reverse transcription. The qPCR 
reaction cocktail (10 μL) was compromised of 1X ExiLENT SYBR® Green Master Mix 
(Exiqon), 1X ROX (Life Technologies, Carlsbad, CA), 1 μL of primer mix, and 2 μL of diluted 
template cDNA. Amplification was performed in the ABI 7900HT real-time thermal cycler in 
“9600 Emulation” mode (Applied Biosystems, Inc., Foster City, CA).  
 
Data Analysis   
 The cattle were sorted based on how much weight they gained during the time that data 
was collected (from Day 0 to Harvest). The median value for weight gain was then determined, 
and the cattle that gained more weight than the median were considered “high gain”, while those 
that gained less weight than the median were labeled as “low gain”. The steer that had the 
median value was not included in the data analysis. The relative expression quantities (RQ) were 
calculated using the relative quantification method as described by Livak and Schmittgen (Livak 
9 
and Schmittgen, 2001). The calibrator that was used was for this experiment was the sample 
collected in August from steer 160.  
 
 Samples that reached the threshold past 35 cycles or failed to reach the threshold before 
the end of the analysis were changed to 45 in order to make the RQ value 0. Furthermore, any 
obvious outliers were removed from the data. The standard error for each group was determined 
and presented using standard error bars. A two-tailed t-test was used in order to determine 
statistical significance.     
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CHAPTER III 
RESULTS AND DISCUSSION  
 
Expression of miR-133b 
The expression of miR-133b in the plasma samples throughout the experiment is 
illustrated in Figure 1. There was a statistically significant difference (P<0.05) between groups 
in April and August (denoted by *). In both the month of April and August, the Low Gain group 
had a significantly higher expression of miR-133b when compared to the High Gain group.  
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Figure 1. Plasma miR-133b Expression in Steers Based on Day 0 to Slaughter Weight Gain.(* 
denotes P<0.05).  
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Expression of miR-27a 
 
 The expression of miR-27a in the plasma samples throughout the experiment is illustrated 
in Figure 2. There was a statistically significant difference (P<0.05) between groups in April and 
August (denoted by *). The Low Gain group in both the months of April and August experience 
a higher expression of miR-27a when compared to the corresponding High Gain group.    
 
 
 
Discussion  
 It was noted that there was a significant increase in expression levels for both miR-27a 
and miR-133b in both the High Gain group and the Low Gain group during the month of May. 
This increase can may be attributed all of the steers entering a growth phase as cattle were placed 
on feed.  
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Figure 2. Plasma miR-27a Expression in steers based on Day 0 to Slaughter Weight Gain (* 
denotes P>0.05).  
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During the months of April and August, the expression level of miR-133b in the Low 
Gain group was significantly higher than that of the High Gain group. One of the functions for 
miR-133b is its role in downregulating IGF-1 expression by regulating IGF- 1 receptors (IGF-
1R) (Huang et al., 2011; Wang, 2013). The receptors are regulated by miR-133b due to it’s 
ability to bind to the 3’UTR of IGF-1R (Huang et al., 2011). This decrease in IGF-1R causes a 
decrease in the phosphorylation of Akt, which ultimately affects the PIK3/Akt signaling 
pathway, which is an integral to skeletal muscle development and growth. (Huang et al., 2011).   
The IGF-1 protein is very important for skeletal muscle growth and development. IGF-1 has 
been identified as an important component for anabolic pathways that are involved in skeletal 
muscle cells (Musarò et al., 2001). Administering IGF-1 to cultured muscle cells has been shown 
to stimulate cell proliferation and then myogenic differentiation (Engert et al., 1996). The 
addition of a locally expressed isoform of IGF-1 has been shown to decrease muscle 
degeneration in mice (Musarò et al., 2001). Therefore, regulating the IGF-1 receptor has effects 
on skeletal muscle growth and development. The results from this experiment are consistent with 
previous results that indicate miR-133b ultimately has a negative effect on muscle growth. The 
higher expression of miR-133b in the Low Gain group when compared to the High Gain group 
during April and August could be an indication of its increased expression and role in the animal 
during these months. Furthermore, the differing levels of expression throughout the months 
could indicate differing amounts of growth that is occurring at the time. Further experiments 
could include measuring the IGF-1 and IGF-1R levels and activity in plasma, in order to observe 
how they relate to the levels of miR-133b. Also, the animals’ growth during times of differing 
miR-133b expression could be examined in order to observe how specific times of high growth 
and low growth alter the plasma miR-133b expression.  
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Research has shown that miR-27a negatively regulates myostatin production by binding 
the 3’UTR of myostatin (Huang et al., 2012). Myostatin, a member of the transforming group 
factor-β superfamily, has been established in its role in skeletal myogenesis and myoblast 
proliferation (Huang et al., 2012).  Myostatin negatively regulates skeletal muscle growth by 
regulating proliferation. It has been found that myostatin ultimately results in an accumulation of 
hypophosphorylated Rb protein, which causes myoblasts to remain in the G1-phase of the cell 
cycle (Thomas et al., 2000). In this experiment, the Low Gain group experienced elevated 
expression of miR-27a in the months of April and August when compared to the respective High 
Gain groups. The increased expression of miR-27a in the Low Gain groups could be an 
indication that since miR-27a is not being used in the muscle, it was excreted into the plasma. In 
future trials, muscle biopsies could be obtained in order to observe the concentration of miR-27a 
in the muscle when compared to miR-27a concentration in the plasma.  One interesting thing to 
consider is that both miR-133b and miR-27a experienced statistically significant data in April 
and in August. This could be an indicator of different periods of growth that are occurring during 
these times.  
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CHAPTER IV 
CONCLUSION 
 
 The expression levels of miR-27a and miR-133b in plasma was observed in Angus-
Nellore steers over a period of 5 months. A significant difference in the expression of miR-133b 
and miR-27a was observed between High Gain and Low Gain groups in the months of April and 
August. In both cases, the Low Gain group had greater expression of microRNA in plasma than 
the High Gain group. The difference in plasma miR-133b expression could be an indication of  
this miRNA acting in order to upregulate skeletal muscle growth and development, while the 
increased expression in miR-27a could be a result from this miRNA not being used in the 
muscle, and thus ending up in plasma. Further research in miR-133b and IGF-1 expression in 
plasma and a comparison in miR-27a in plasma and muscle could be performed in order to test 
this hypothesis.  
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